Sharing on a sponsor’s perspective is Dr Christopher Fang, Worldwide Director,Clinical Research&Medical Affairs, DePuy Spine, Johnson & Johnson, United States. He will be speaking at Pharma Trials World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012.
Dr Christopher Fang brings a wealth of experience in both medical device and pharmaceutical industries. He has worked to improve healthcare through innovation in biomedical technology. Dr Fang serves as the Worldwide Director of Clinical Research and Medical Affairs for Johnson & Johnson, DePuy Spine. He has been charged with establishing the global clinical organization, research process, and evidence strategy for the $1 Billion operating company. Dr Fang is appointed to a variety of strategic assignments related to new product development, reimbursement, and business development. He serves as the Chair of the Clinical Research Committee responsible for selection and management of clinical programs. Representing Johnson & Johnson globally, he maintains an active role in working to influence healthcare policies that will impact the approval and payment of innovative technologies in the future.
Dr Fang's career began at Novartis/Idenix Pharmaceuticals where he led two global registration trials for Hepatitis B. He was later appointed as Head of Cardiovascular Research and Medical Director at Mitsubishi Pharma Corporation before moving on to Medtronic Vascular. As the Director of Clinical Affairs and Head of Global Clinical Safety, he was responsible for coronary and peripheral device trials. Dr Fang was awarded the prestigious Eisenhower Fellowships for 2011.
Dr Fang will be presenting on the following:
Sponsor's perspective: Utilizing clinical technology to accelerate your trial progress
1. Overcoming inherent challenges of technology use to enhance the patient-physician relationship
2. Steering future technological advancements for increased control of trial design and direction in clinical trials